Scarica l'app Stockscreener
4.365
5.11%
-0.235
Pre-mercato:
4.31
-0.055
-1.26%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PYXS Giù?
Forum
Previsione
Precedente Chiudi:
$4.60
Aprire:
$4.52
Volume 24 ore:
701.89K
Relative Volume:
0.82
Capitalizzazione di mercato:
$271.78M
Reddito:
-
Utile/perdita netta:
$-73.79M
Rapporto P/E:
-2.3723
EPS:
-1.84
Flusso di cassa netto:
$-77.44M
1 W Prestazione:
-17.33%
1M Prestazione:
+11.92%
6M Prestazione:
+241.02%
1 anno Prestazione:
+142.50%
Intervallo 1D:
$4.25
$4.59
Intervallo di 1 settimana:
$3.67
$5.42
Portata 52W:
$0.8332
$5.55
Pyxis Oncology Inc Stock (PYXS) Company Profile
Nome
Pyxis Oncology Inc
Settore
Industria
Telefono
(617) 221-9059
Indirizzo
321 HARRISON AVENUE, BOSTON
Confronta PYXS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
4.365 | 286.42M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Ripresa | Stifel | Buy |
| 2025-09-04 | Iniziato | Guggenheim | Buy |
| 2024-11-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-11-08 | Iniziato | Stephens | Overweight |
| 2024-08-08 | Iniziato | Stifel | Buy |
| 2024-05-07 | Ripresa | Jefferies | Buy |
| 2024-02-09 | Iniziato | BTIG Research | Buy |
| 2024-01-23 | Iniziato | Leerink Partners | Outperform |
| 2023-09-05 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-11-02 | Iniziato | BofA Securities | Neutral |
| 2021-11-02 | Iniziato | Credit Suisse | Outperform |
| 2021-11-02 | Iniziato | Jefferies | Buy |
Mostra tutto
Pyxis Oncology Inc Borsa (PYXS) Ultime notizie
Will Pyxis Oncology Inc. stock reach Wall Street targetsPortfolio Value Report & Risk Controlled Daily Trade Plans - Newser
Its Stock Has Paid Off Big Time For Pyxis Oncology Inc - Setenews
Pyxis Oncology Keeps Losses Steady As It Eyes Key Trial Data - Finimize
Leerink Partnrs Lowers Earnings Estimates for Pyxis Oncology - Defense World
Pyxis Oncology Files $350 Million Mixed Shelf - marketscreener.com
Pyxis Oncology: MICVO Data Could Be The Tipping Point In 2025 - RTTNews
What drives Pyxis Oncology Inc stock priceStock Screening Results & Free Real-Time Trading Signals - earlytimes.in
Stephens Reaffirms Their Buy Rating on Pyxis Oncology (PYXS) - The Globe and Mail
Stephens & Co. Maintains Pyxis Oncology (PYXS) Overweight Recommendation - Nasdaq
Stephens raises Pyxis Oncology stock price target to $8 on MICVO potential - Investing.com Nigeria
Ready to Jump After Recent Trade: Pyxis Oncology Inc (PYXS) - Setenews
Can Pyxis Oncology Inc. stock weather global recessionSell Signal & Weekly Return Optimization Plans - newser.com
Is Pyxis Oncology Inc. stock vulnerable to regulatory risksPortfolio Value Report & Weekly Momentum Picks - newser.com
What makes Pyxis Oncology Inc. stock attractive to growth funds2025 Market Outlook & Growth Focused Investment Plans - newser.com
Signal strength of Pyxis Oncology Inc. stock in tech scanners - newser.com
Tick level data insight on Pyxis Oncology Inc. volatilityJuly 2025 Decliners & Capital Efficient Trade Techniques - newser.com
Is Pyxis Oncology Inc. stock a bargain at current levels2025 Volatility Report & Weekly Consistent Profit Watchlists - newser.com
Applying Elliott Wave Theory to Pyxis Oncology Inc.July 2025 Fed Impact & Expert Approved Momentum Trade Ideas - newser.com
Can trapped investors hope for a rebound in Pyxis Oncology Inc.2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - newser.com
Pyxis Oncology Reports Increased Losses Amid Development Focus - TipRanks
Pyxis Oncology Inc (PYXS) looking to reclaim success with recent performance - Setenews
How to manage a losing position in Pyxis Oncology Inc.July 2025 Spike Watch & Community Consensus Trade Signals - newser.com
Is Pyxis Oncology Inc. stock gaining market shareJobs Report & Verified Chart Pattern Signals - newser.com
Is Pyxis Oncology Inc. stock cheap at current valuationJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
Pyxis Oncology (PYXS) Price Target Increased by 13.33% to 6.94 - Nasdaq
Ranking Pyxis Oncology Inc. among high performing stocks via toolsQuarterly Risk Review & Daily Oversold Bounce Ideas - newser.com
What Fibonacci levels say about Pyxis Oncology Inc. reboundMarket Growth Summary & Stock Portfolio Risk Control - newser.com
Backtesting results for Pyxis Oncology Inc. trading strategiesMarket Sentiment Review & Growth Focused Investment Plans - newser.com
Published on: 2025-11-16 11:45:49 - newser.com
Will Pyxis Oncology Inc. stock continue upward momentumDividend Hike & AI Forecast for Swing Trade Picks - newser.com
Can Pyxis Oncology Inc. stock beat analyst upgradesIPO Watch & Weekly Chart Analysis and Trade Guides - newser.com
Brokerages Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $7.25 - Defense World
Will Pyxis Oncology Inc. stock see insider buyingStop Loss & Weekly Watchlist for Hot Stocks - Fundação Cultural do Pará
Stifel Nicolaus Remains a Buy on Pyxis Oncology (PYXS) - The Globe and Mail
Will Pyxis Oncology Inc. stock deliver better than expected guidancePortfolio Risk Summary & Verified Entry Point Signals - newser.com
Pyxis Oncology Inc Azioni (PYXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):